Moderna CEO Stephane Bancel believes the personalized mRNA cancer vaccine being developed with Merck will work in a variety of tumors. Speaking with Romaine Bostick on "Bloomberg The Close," Bancel also says the recent data leak for the cancer vaccine candidate did not come from either Moderna or Merck. (Source: Bloomberg)
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.